We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$982M
AUM Growth
+$77.1M
Cap. Flow
+$15.2M
Cap. Flow %
1.55%
Top 10 Hldgs %
45.19%
Holding
710
New
276
Increased
121
Reduced
95
Closed
168

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$76.4M
2
PFE icon
Pfizer
PFE
+$45.1M
3
URI icon
United Rentals
URI
+$38.7M
4
TSM icon
TSMC
TSM
+$34.1M
5
AMZN icon
Amazon
AMZN
+$12.8M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$179M
2
APTV icon
Aptiv
APTV
+$89.5M
3
CRM icon
Salesforce
CRM
+$21.7M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.5M
5
SLV icon
iShares Silver Trust
SLV
+$6.83M

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Technology 15.33%
3 Industrials 7.88%
4 Financials 6.49%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSPN icon
501
OneSpan
OSPN
$603M
$185K 0.02%
10,924
GRTS
502
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$177K 0.02%
+13,797
New +$153K
KOS icon
503
Kosmos Energy
KOS
$1.49B
$164K 0.02%
+47,404
New +$170K
CHS
504
DELISTED
Chicos FAS, Inc.
CHS
$164K 0.02%
+30,575
New +$166K
AQST icon
505
Aquestive Therapeutics
AQST
$538M
$163K 0.02%
+42,028
New +$211K
QTTB icon
506
Q32 Bio
QTTB
$466M
$157K 0.02%
2,392
+1,663
+228% +$161K
OIS icon
507
Oil States International
OIS
$534M
$155K 0.02%
+31,203
New +$184K
CCO icon
508
Clear Channel Outdoor Holdings
CCO
$1.23B
$154K 0.02%
46,408
+35,794
+337% +$111K
TCRT icon
509
Alaunos Therapeutics
TCRT
$4.84M
$154K 0.02%
+942
New +$207K
NLY icon
510
Annaly Capital Management
NLY
$17.3B
$148K 0.02%
4,720
-15,037
-76% -$505K
PFLT icon
511
PennantPark Floating Rate Capital
PFLT
$734M
$143K 0.01%
11,196
TTI icon
512
TETRA Technologies
TTI
$1.28B
$143K 0.01%
50,316
LAUR icon
513
Laureate Education
LAUR
$5.13B
$142K 0.01%
+11,586
New +$152K
FNB icon
514
FNB Corp
FNB
$6.75B
$141K 0.01%
11,644
-8,278
-42% -$100K
TECX
515
Tectonic Therapeutic
TECX
$639M
$141K 0.01%
+3,060
New +$176K
EDU icon
516
New Oriental
EDU
$9.24B
$123K 0.01%
5,839
-6,665
-53% -$144K
WTI icon
517
W&T Offshore
WTI
$577M
$120K 0.01%
37,088
-2,273
-6% -$8.75K
PRVB
518
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$119K 0.01%
+21,198
New +$135K
PGRE
519
DELISTED
Paramount Group
PGRE
$118K 0.01%
+14,136
New +$125K
XBIT icon
520
XBiotech
XBIT
$69.5M
$115K 0.01%
10,309
SUP
521
DELISTED
Superior Industries International
SUP
$114K 0.01%
25,397
WSR
522
DELISTED
Whitestone REIT
WSR
$107K 0.01%
10,565
TCRR
523
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$106K 0.01%
+22,784
New +$142K
GOTU icon
524
Gaotu Techedu
GOTU
$444M
$105K 0.01%
+53,923
New +$150K
CRVS icon
525
Corvus Pharmaceuticals
CRVS
$1.16B
$104K 0.01%
+43,325
New +$168K

Similar funds

Caxton Associates (New York)'s Q4 2021 Portfolio in Review

As of Q4 2021, Caxton Associates (New York) held 710 positions worth $982M, up 8.5% from $905M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Caxton Associates (New York)'s Q4 2021 filing shows 276 new, 121 increased, 95 reduced and 168 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 166,431 shares worth $79M. The largest sale was Tesla, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Caxton Associates (New York)'s largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 166,431 shares worth $79M.
  • Caxton Associates (New York) added most to Pfizer in Q4 2021, an estimated $45.1M increase.
  • Caxton Associates (New York)'s biggest Q4 2021 reduction was Tesla, cutting an estimated $179M.
  • Caxton Associates (New York) fully exited Aptiv in Q4 2021, selling an estimated $89.5M.
  • Caxton Associates (New York)'s ten largest holdings make up 45% of its $982M portfolio in Q4 2021.
  • Caxton Associates (New York) opened 276 new positions and closed 168 in Q4 2021.
  • Caxton Associates (New York)'s portfolio value rose 8.5% quarter-over-quarter to $982M.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.